Back to Company Profile

MédiMabs has created a state-of-the-art antibodies R&D and production facility. All scale-up preparations of licensed antibodies, R&D projects as well as the de novo generation of new antibodies are carried out in this facility. Being the producer of new research tools as well as Mabs and Pabs confers to MédiMabs full control over quality, ensures timely distribution and allows for the development and production of highly detailed agent specification sheets and detailed notes.

Research and Development

Development of New Research Tools

MédiMabs can help respond to individual researcher’s needs by developing new antibody specific tools tailored to their specific project. It continuously seeks out new opportunities for the development of research tools to respond to the scientific community’s needs in antibody application fields.

De novo generation of antibodies

MédiMabs develops new monoclonal and polyclonal antibodies from existing or newly discovered proteins. It carries out research and analysis for the purpose of design of peptide proteins  for the generation of new Mabs and Pabs.

Peptide Design and Synthesis

Medimabs’ scientific team carries out extensive analysis of protein sequences to select appropriate amino acid sequences. It is equipped to provide expert peptide design and synthesis services and advice for any protein for which and antibody needs to be generated.

Licensing of Antibodies

Existing Monoclonal Antibodies

MédiMabs understands that much time and effort is expended in the development of antibodies in research laboratories. However, although these agents are valuable and have a definite commercial potential within the same research community, only a small percentage of these are adequately exploited.  MédiMabs has consequently devised a royalty based compensation program to facilitate the licensing and the marketing of such antibodies, thus rendering the licensing process a rewarding one for academic institutions and research in general. MédiMabs’ policy is one of direct dialogue with suppliers (Academic and industrial Technology Transfer Offices, researchers etc.) and customers (Academic and industrial researchers).